Quest Diagnostics (DGX) Reports In-Line Q3 EPS, Revenues Miss; Lowers FY18 EPS/Reveunes Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Quest Diagnostics (DGX) PT Lowered to $121 at Credit Suisse
October 24, 2018 8:47 AM EDTCredit Suisse analyst A.J. Rice lowered the price target on Quest Diagnostics (NYSE: DGX) to $121.00 (from $128.00) while maintaining an Outperform rating following results.
Rice said Long-term Tailwinds Still in Play, Despite a Short-term Speed Bump.
... MoreQuest Diagnostics (DGX) Reports Acquisition of Hurley Medical Center's Outreach Laboratory Services Operation in Central Michigan
October 22, 2018 9:32 AM EDT3 Quest Diagnostics (NYSE: DGX) today announced it has acquired certain assets of the outreach laboratory services operation of Hurley Medical Center, a leading regional provider of healthcare services.
Patients and providers in central Michigan will have access to Quest's broader range of diagnostic services, a... More
BofA/Merrill Lynch Reinstates Quest Diagnostics (DGX) at Buy
October 19, 2018 6:09 AM EDTBofA/Merrill Lynch analyst Derik de Bruin reinstates coverage on Quest Diagnostics (NYSE: DGX) with a Buy rating and a price target of $116.00.
For an analyst ratings summary and ratings history on Quest Diagnostics... More
